Cáncer de próstata resistente a la castración. Recomendaciones de consenso de la Asociación Española de Urología
Saved in:
Published in | Actas urologicas españolas Vol. 41; no. 3; pp. 141 - 145 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | Spanish |
Published |
Elsevier España, S.L.U
01.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Author | Miñana, B Lacasa-Viscasillas, I Loizaga-Iriarte, A Senarriaga-Ruiz de la Illa, N Cozar-Olmo, J.M Rodriguez-Antolin, A Unda-Urzaiz, M |
---|---|
Author_xml | – sequence: 1 fullname: Loizaga-Iriarte, A – sequence: 2 fullname: Rodriguez-Antolin, A – sequence: 3 fullname: Miñana, B – sequence: 4 fullname: Lacasa-Viscasillas, I – sequence: 5 fullname: Senarriaga-Ruiz de la Illa, N – sequence: 6 fullname: Cozar-Olmo, J.M – sequence: 7 fullname: Unda-Urzaiz, M |
BookMark | eNqFkUtqHDEQQEWwIePPCbLpC3S7pP5JixiGYZwYDIbEXguNujpo0pYGVc-Aj5MDeBF8hL5Y1B6vsvGqqqR6ovTqjJ344JGxLxwKDry52hbG7mMoRCoKUAUA_8QWvFEqb5WEE7YAwSGvJDSf2RnRFkBUpWwX7LCa_niLMesw28XplUYzmiwiORrRj5iZbDCZNTRGY9306ovsB9rwhL5LdZqCZtIGT-gpzHlqX1Kw7tierWlnpr8hnaa7xxiG8Gt6MRfstDcD4eV7PGePN-uH1ff87v7b7Wp5l1tRw5hXva0k8q5r5UbWZQNKtFj1IKGVooROVjWirKBWgvccUIHYcCtEXye-3vDynJXHd20MRBF7vYvuycRnzUHP6vRWv6nTszoNSid1ifp6pDCNdnAYNVmHSVPnItpRd8F9wF__x9vBeWfN8BufkbZhH336teaahAb9c17OvBvelIkGVf4Da0eTjQ |
Cites_doi | 10.1016/S0140-6736(10)62344-6 10.1016/S0025-7753(03)73601-X 10.1111/j.1464-410X.2010.09638.x 10.1200/JCO.2007.12.4487 10.1016/S0094-0143(05)70070-7 10.1016/j.ejca.2008.10.026 10.1200/JCO.2005.01.529 10.1007/s00256-014-1903-9 10.1200/JCO.2015.64.2702 10.1016/j.eururo.2014.07.028 |
ContentType | Journal Article |
Copyright | AEU 2016 AEU |
Copyright_xml | – notice: AEU – notice: 2016 AEU |
DBID | AAYXX CITATION |
DOI | 10.1016/j.acuro.2016.09.001 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Castrate resistant prostate cancer. Consensus recommendations of the Spanish Association of Urology |
EISSN | 1699-7980 |
EndPage | 145 |
ExternalDocumentID | 10_1016_j_acuro_2016_09_001 S0210480616301309 1_s2_0_S0210480616301309 |
GroupedDBID | 0R 2WC 457 53G 5GY 65R 6J9 77F AACTN AAEDT AALRI AAQXK AAXUO ABXHO ACGFS ADACO ADBBV ADCUG AENEX AEVXI AFTJW ALMA_UNASSIGNED_HOLDINGS APOWU ASPBG AVWKF AZFZN BAWUL C1A DIK E3Z EBS EJD F5P FDB FEDTE FGOYB FIRID GX1 HVGLF HZ IPNFZ O9- OK1 P2P R2- RIG RSK SCD SES TR2 XSB Z7D 0R~ ABJNI ADMUD HZ~ AAYXX AMRAJ CITATION |
ID | FETCH-LOGICAL-c250t-4fc48e1dd78b85360927e4f08078230d845ee8405921f10e902b1c22f5c255b13 |
ISSN | 0210-4806 |
IngestDate | Fri Aug 23 03:55:49 EDT 2024 Fri Feb 23 02:21:30 EST 2024 Thu Aug 18 17:28:12 EDT 2022 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 3 |
Language | Spanish |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c250t-4fc48e1dd78b85360927e4f08078230d845ee8405921f10e902b1c22f5c255b13 |
OpenAccessLink | https://medes.com/publication/119699 |
PageCount | 5 |
ParticipantIDs | crossref_primary_10_1016_j_acuro_2016_09_001 elsevier_sciencedirect_doi_10_1016_j_acuro_2016_09_001 elsevier_clinicalkeyesjournals_1_s2_0_S0210480616301309 |
PublicationCentury | 2000 |
PublicationDate | 2017-04-01 |
PublicationDateYYYYMMDD | 2017-04-01 |
PublicationDate_xml | – month: 04 year: 2017 text: 2017-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationTitle | Actas urologicas españolas |
PublicationYear | 2017 |
Publisher | Elsevier España, S.L.U |
Publisher_xml | – name: Elsevier España, S.L.U |
References | EAU Guidelines 2016. [consultado 10 Abr 2016]. Disponible en Smith, Kabbinavar, Saad, Hussain, Gittelman, Bilhartz (bib0125) 2005; 23 Nicholas, Armelle, Heather, Jia (bib0095) 2010; 106 NCCN Clinical practice guidelines in oncology: Prostate cancer. Version 2.2016. [consultado 10 Abr 2016]. Disponible en Badia, Muriel, Gracia, Núñez-Olarte, Perulero, Gálvez (bib0115) 2003; 120 Brasso, Thomsen, Schrader, Schmid, Lo rente, Retz (bib0135) 2015; 68 Scher, Halabi, Tannock, Underwood, Wang, DePalantino (bib0105) 2008; 26 AUA castration-resistant prostate cancer guideline. [consultado 10 Abr 2016]. Disponible en Fizazi, Carducci, Smith, Damiao, Brown, Karsh (bib0140) 2011; 377 George, Kantoff (bib0120) 1999; 26 Eisenhauer, Therasse, Bogaerts, Schwartz, Sargent, Ford (bib0130) 2009; 45 Ryan, Crawford, Shore, Borre, Zonnenberg, Beuzeboc (bib0100) 2014; 32 Scher, Morris, Stadler, Morris, Sternberg, Carducci (bib0145) 2016; 34 Shen, Deng, Hu (bib0090) 2014; 43 Scher (10.1016/j.acuro.2016.09.001_bib0145) 2016; 34 Fizazi (10.1016/j.acuro.2016.09.001_bib0140) 2011; 377 10.1016/j.acuro.2016.09.001_bib0080 Smith (10.1016/j.acuro.2016.09.001_bib0125) 2005; 23 10.1016/j.acuro.2016.09.001_bib0085 10.1016/j.acuro.2016.09.001_bib0075 George (10.1016/j.acuro.2016.09.001_bib0120) 1999; 26 Brasso (10.1016/j.acuro.2016.09.001_bib0135) 2015; 68 Nicholas (10.1016/j.acuro.2016.09.001_bib0095) 2010; 106 Shen (10.1016/j.acuro.2016.09.001_bib0090) 2014; 43 Badia (10.1016/j.acuro.2016.09.001_bib0115) 2003; 120 Ryan (10.1016/j.acuro.2016.09.001_bib0100) 2014; 32 Scher (10.1016/j.acuro.2016.09.001_bib0105) 2008; 26 Eisenhauer (10.1016/j.acuro.2016.09.001_bib0130) 2009; 45 |
References_xml | – volume: 377 start-page: 813 year: 2011 end-page: 822 ident: bib0140 article-title: Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study publication-title: Lancet contributor: fullname: Karsh – volume: 23 start-page: 2918 year: 2005 end-page: 2925 ident: bib0125 article-title: Natural history of rising serum prostate-specific antigen in men with castrate non-metastatic prostate cancer publication-title: J Clin Oncol contributor: fullname: Bilhartz – volume: 120 start-page: 52 year: 2003 end-page: 59 ident: bib0115 article-title: Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica publication-title: Med Clin (Barc) contributor: fullname: Gálvez – volume: 45 start-page: 228 year: 2009 end-page: 247 ident: bib0130 article-title: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) publication-title: Eur J Cancer contributor: fullname: Ford – volume: 34 start-page: 1402 year: 2016 end-page: 1418 ident: bib0145 article-title: Trial design and objectives for castration- resistant prostate cancer: Updated recommendations from the Prostate Cancer Clinical Trials Working Group 3 publication-title: J Clin Oncol. contributor: fullname: Carducci – volume: 26 start-page: 303 year: 1999 end-page: 310 ident: bib0120 article-title: Prognostic indicators in hormone refractory prostate cancer publication-title: Urol Clin North Am contributor: fullname: Kantoff – volume: 68 start-page: 317 year: 2015 end-page: 324 ident: bib0135 article-title: Enzalutamide antitumour activity against metastatic castration-resistant prostate cancer previously treated with docetaxel and abiraterone: A multicentre analysis publication-title: Eur Urol contributor: fullname: Retz – volume: 32 start-page: 5s year: 2014 ident: bib0100 article-title: Effect of abiraterone acetate and low-dose prednisone on PSA in patients with nonmetastatic castration-resistant prostate cancer: The results from IMAAGEN core study publication-title: J Clin Oncol contributor: fullname: Beuzeboc – volume: 26 start-page: 1148 year: 2008 end-page: 1159 ident: bib0105 article-title: Design and points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group publication-title: J Clin Oncol contributor: fullname: DePalantino – volume: 43 start-page: 1503 year: 2014 end-page: 1513 ident: bib0090 article-title: Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: A meta-analysis publication-title: Skeletal Radiol contributor: fullname: Hu – volume: 106 start-page: 966 year: 2010 end-page: 973 ident: bib0095 article-title: Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: A double-blind, placebo-controlled, randomized Phase II trial publication-title: BJU Int contributor: fullname: Jia – volume: 377 start-page: 813 year: 2011 ident: 10.1016/j.acuro.2016.09.001_bib0140 article-title: Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study publication-title: Lancet doi: 10.1016/S0140-6736(10)62344-6 contributor: fullname: Fizazi – volume: 120 start-page: 52 year: 2003 ident: 10.1016/j.acuro.2016.09.001_bib0115 article-title: Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica publication-title: Med Clin (Barc) doi: 10.1016/S0025-7753(03)73601-X contributor: fullname: Badia – volume: 106 start-page: 966 year: 2010 ident: 10.1016/j.acuro.2016.09.001_bib0095 publication-title: BJU Int doi: 10.1111/j.1464-410X.2010.09638.x contributor: fullname: Nicholas – ident: 10.1016/j.acuro.2016.09.001_bib0075 – volume: 26 start-page: 1148 year: 2008 ident: 10.1016/j.acuro.2016.09.001_bib0105 article-title: Design and points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group publication-title: J Clin Oncol doi: 10.1200/JCO.2007.12.4487 contributor: fullname: Scher – ident: 10.1016/j.acuro.2016.09.001_bib0080 – volume: 26 start-page: 303 year: 1999 ident: 10.1016/j.acuro.2016.09.001_bib0120 article-title: Prognostic indicators in hormone refractory prostate cancer publication-title: Urol Clin North Am doi: 10.1016/S0094-0143(05)70070-7 contributor: fullname: George – volume: 45 start-page: 228 year: 2009 ident: 10.1016/j.acuro.2016.09.001_bib0130 article-title: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) publication-title: Eur J Cancer doi: 10.1016/j.ejca.2008.10.026 contributor: fullname: Eisenhauer – volume: 32 start-page: 5s issue: suppl abstr 5086 year: 2014 ident: 10.1016/j.acuro.2016.09.001_bib0100 article-title: Effect of abiraterone acetate and low-dose prednisone on PSA in patients with nonmetastatic castration-resistant prostate cancer: The results from IMAAGEN core study publication-title: J Clin Oncol contributor: fullname: Ryan – volume: 23 start-page: 2918 year: 2005 ident: 10.1016/j.acuro.2016.09.001_bib0125 article-title: Natural history of rising serum prostate-specific antigen in men with castrate non-metastatic prostate cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2005.01.529 contributor: fullname: Smith – ident: 10.1016/j.acuro.2016.09.001_bib0085 – volume: 43 start-page: 1503 year: 2014 ident: 10.1016/j.acuro.2016.09.001_bib0090 article-title: Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: A meta-analysis publication-title: Skeletal Radiol doi: 10.1007/s00256-014-1903-9 contributor: fullname: Shen – volume: 34 start-page: 1402 year: 2016 ident: 10.1016/j.acuro.2016.09.001_bib0145 article-title: Trial design and objectives for castration- resistant prostate cancer: Updated recommendations from the Prostate Cancer Clinical Trials Working Group 3 publication-title: J Clin Oncol. doi: 10.1200/JCO.2015.64.2702 contributor: fullname: Scher – volume: 68 start-page: 317 year: 2015 ident: 10.1016/j.acuro.2016.09.001_bib0135 article-title: Enzalutamide antitumour activity against metastatic castration-resistant prostate cancer previously treated with docetaxel and abiraterone: A multicentre analysis publication-title: Eur Urol doi: 10.1016/j.eururo.2014.07.028 contributor: fullname: Brasso |
SSID | ssj0024387 |
Score | 2.0220087 |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | 141 |
SubjectTerms | Urology |
Title | Cáncer de próstata resistente a la castración. Recomendaciones de consenso de la Asociación Española de Urología |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0210480616301309 https://dx.doi.org/10.1016/j.acuro.2016.09.001 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKcuGCQIAoL-XALTiKU-d17JaFBe1yYYt6s-zEWXW1Sqsk5dB_sz9gD2h_Qs_8J2bivLRUK5ZL6_oV1_NlHvZ4TMj7SRB4XPqaYrw9ytM4oyrzFQ00SPcwSHWk8DTy6bfgeM6_LvzFaPR74LW0qZSTbPeeK_kfqkIe0BVPyd6Dsl2nkAFpoC98AoXh859oPKu3uRnQDa_5ttf1tvfhBA8JSRvsaCQhTJwt7UtpJxJXNZKlqZM7qDFi-IUU8jBgP_aQoG91Xq4wDU2mNem6JvYRsJ86zcAgxjrzAnlnPYqPcqjnTpNKlvamaFhraeth006PP1ktt_Jc0i8wWYW5qG_q9HtAabE83-gtnebVqrlYvi8-NcNi0pxqO-wKTiQ8UNIfyxK-8VIlwwid4QIHCM3eL8bwQbBKKY_cYMi0ORuAczLgwKwp0c0vf6-cMEsWF4BZmAl08AscE7i0F4utK8Atadn5MLbucRei7kRgJ8KN0UnwAXnohbGPawGfF2wQ-rG-r7H7P20QrNrd8K-R7FeUBsrP2RPyuLFarKmB4FMy0uUz8nO2u0LoWam21sXupoad1cPOktaltFrY7W5yx7oFOWzZQg7TUL2FHFS3EG67X4AXLDNQ213L52T-6ehsdkybazxoAvp1RXmW8EizNA0jBcph4MZeqHnm4k0HYACnEfe1jsBwiD2WMVfHrqdY4nmZD-19xSYvyEEOg3pJLKYgP8wU1zzmapIqlcRZBELIDz0V8nRMPrRzJtYmWou4g05jErbzKtqDyCA6ddm846VgovSEK74jzZBkYL3gVn88JkHXslFVjQoqAGF3PfLV_Ub4mjzqX4k35KAqNvotaMGVeldj6w_VF7Hh |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=C%C3%A1ncer+de+pr%C3%B3stata+resistente+a+la+castraci%C3%B3n.+Recomendaciones+de+consenso+de+la+Asociaci%C3%B3n+Espa%C3%B1ola+de+Urolog%C3%ADa&rft.jtitle=Actas+urologicas+espa%C3%B1olas&rft.au=Loizaga-Iriarte%2C+A.&rft.au=Rodriguez-Antolin%2C+A.&rft.au=Mi%C3%B1ana%2C+B.&rft.au=Lacasa-Viscasillas%2C+I.&rft.date=2017-04-01&rft.issn=0210-4806&rft.volume=41&rft.issue=3&rft.spage=141&rft.epage=145&rft_id=info:doi/10.1016%2Fj.acuro.2016.09.001&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_acuro_2016_09_001 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F02104806%2FS0210480617X00028%2Fcov150h.gif |